MoatScopeMoatScope
Spin-offs/Corteva, Inc.Vylor Inc.

Vylor Inc.

Spin-off from Corteva, Inc. (CTVA) · Expected Oct 1, 2026 · NYSE

Announced
Oct 1, 2025
Form 10 filed
Jun 29, 2026
Record date
Expected distribution
Oct 1, 2026
Ratio
TBD
Debt loaded
Cash to parent
Latest filing
Aug 14, 2026

ratio left blank in the latest amendment

Documents

Both companies today

The new company
Vylor Inc.

No ticker yet; the numbers follow the listing.

The parent
Corteva, Inc.CTVA
Market cap
$59.7B
Moat
Narrow
Quality
50
Price
$87.86
Fair value
$68.24
Price / FV
1.26×

Moat ratings, quality scores and fair value estimates are MoatScope research opinions and refresh with the data pipeline. Price / FV below 1.00× means the shares trade under our base-case estimate.

What is being separated

Vylor will hold Corteva's seed business, including its licensing, gene editing, hybrid wheat and biofuels growth platforms, as a stand-alone NYSE-listed company. Corteva keeps the crop protection business, positioned around differentiated agricultural solutions including biologicals. Vylor will take on new debt at separation and pay a cash distribution up to Corteva's EIDP subsidiary; the amounts are not yet stated in the filing.

Stated rationaleCorteva's board calls the separation the best available opportunity to enhance the long-term value of both businesses, giving seed and crop protection focused strategies and their own capital allocation.

The four questions

Indiscriminate selling

Absent
Will holders dump the new shares regardless of price?
Loading…

Management incentives

Strong
Are the people running it paid in its own stock?
Loading…

The hidden jewel

Strong
Is a better business being uncovered — on either side?
Loading…

Leverage

Partial
Does the debt turn the equity into a leveraged bet?
Loading…
Which leg to own
The new company
Where we are on the calendar
Before the distribution
VerdictWatch

The write-up

Corteva is splitting itself into the two halves it was assembled from in 2019: the seed business, which becomes Vylor, and crop protection, which keeps the Corteva name. Unusually for a spin-off, the piece being distributed is the larger and better half. Seed produced $9.9 billion of 2025 net sales against $7.5 billion for crop protection, and it is the half with the technology franchise — germplasm, gene editing, hybrid wheat, biofuels and a licensing business that has turned the net royalty line from a cost into a growing source of income. The parent's stated case is that each business will do better with its own strategy and capital allocation. The more telling fact is who is going where.

Loading the rest of the write-up…

Not investment advice. Terms are as stated in the latest filing; spin-off shares are often thinly covered and volatile in their first months. Write-up dated Sep 8, 2026.